LAVQX
Price
$15.52
Change
+$0.10 (+0.65%)
Updated
Jul 3 closing price
Net Assets
2B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LAVQX vs VIVAX

Header iconLAVQX vs VIVAX Comparison
Open Charts LAVQX vs VIVAXBanner chart's image
Lord Abbett Fundamental Equity R2
Price$15.52
Change+$0.10 (+0.65%)
VolumeN/A
Net Assets2B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LAVQX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVQX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVQX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. LAVQX (2B). VIVAX pays higher dividends than LAVQX: VIVAX (2.06) vs LAVQX (0.52). LAVQX was incepted earlier than VIVAX: LAVQX (18 years) vs VIVAX (33 years). LAVQX (1.30) is less costly to investors than VIVAX (0.17). LAVQX is a more actively managed with annual turnover of: 39.00 vs. VIVAX (9.00). LAVQX has a lower initial minimum investment than VIVAX: LAVQX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. LAVQX (8.57). VIVAX return over 5 years is better than : 80.14 vs. LAVQX (57.79).
LAVQXVIVAXLAVQX / VIVAX
Total Expense Ratio1.300.17765%
Annual Report Gross Expense Ratio1.300.17765%
Fund Existence18 years33 years-
Gain YTD6.2296.209100%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2B189B1%
Annual Yield % from dividends0.522.0625%
Returns for 1 year8.5712.0471%
Returns for 3 years37.2335.16106%
Returns for 5 years57.7980.1472%
Returns for 10 years22.69115.7420%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings